Drug of Abuse Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029 A considerable rise in cases of drug abuse due to opium dependency and confusion between CBD based medical marijuana and marijuana that creates a high is emphasizing the need for drug abuse testing. Increase in mortality rate due to drug abuse is causing the governments to impose strict regulations to make drug of abuse tests mandatory for employment, criminal justice cases and protection for social causes. Besides the advancements in test equipment technology that facilitate quick and ultrasensitive detections of newly formulated abusive drugs. Above mentioned the market stimulants causing a significant upsurge in the global drug of abuse testing market. The global drug of abuse testing market is to triumph with fabulous global market value overpassing $11 billion marks by 2026 end and registering a CAGR of 7.3% during the forecast period from 2019 to 2026. Substance Abuse and Mental Health Services Administration (SAMHSA) guidelines govern the collection criteria, a database about companies conducting employment screening, the test that cleared over-the-counter use, specimen testing of substituted or diluted drugs that are habit-forming, whereas FDA regulates drugs of abuse tests mainly by reviewing the design and performance of tests that are widely sold to consumers and healthcare professionals. The drug of abuse tests manufacturers equipped with insights to updated data submitted to SAMSHA and the FDA would be able to fare well in the market. Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=12&page=requestsample Restraints Hampering the Growth of Drug of Abuse Testing Market • Shortage of experienced technicians for the drug of abuse testing • Issues with privacy rights in certain countries • The inability of tests to detect abusive drugs designed with non-detectable traces of forbidden substances. Global Drug of Abuse Testing, by Test Type: • Immunoassay Test • Point-of-Care Tests • Chromatography Tests The prominence of most common, quick and inexpensive drug screening test preferred for initial screening is reserved by immunoassay tests and hence hold a key share in the drug of abuse testing market. As the need for portable consumer-centric convenient diagnosis is gaining traction, point-of-care tests segment is estimated to grow at a lucrative CARG in the near future. Global Drug of Abuse Testing, by Sample Type: • Urine • Blood • Saliva Global Drug of Abuse Testing, by End User: • Pathology Laboratories • Hospitals • Rehabilitation Centers • Federal Agencies • Forensic Laboratories • Clinics • Others Global Drug of Abuse Testing, by Region: • Europe • North America • APAC • Latin America • Rest of World North America market witnessed significant share due to stringent federal policies. It was followed by the European drug of abuse testing market with stable market growth over the forecast period. The Europe market is poised to value over $ 4 billion by the end of 2026. The Asia Pacific and Latin America to witness the fastest CAGR due to increasing awareness. Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=12&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points Objectives of the Study: • To provide with an exhaustive analysis on the global drug of abuse testing market on the basis of test type, sample type, end-user and region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and overall market • To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Introduction 1.1. Scope and Objective 1.2. Assumptions and Acronyms 1.3. Forecast Factors 1.4. Research Methodology 2. Executive Summary 2.1. Industry Cluster Analysis 2.2. Competition Matrix 2.3. Strategies Recommendations 3. Market Definition 3.1. Report Scope (Inclusions & Exclusions) 3.2. Market Segmentation 4. Global Drug of Abuse Testing Market Overview 4.1. Global Drug of Abuse Testing Market Revenue (USD Mn) 5. Key Inclusions 5.1. Porter’s Five Force analysis 5.2. Market Dynamics 5.3. Industry Trends 5.4. Regulatory Guidelines 5.5. Opportunities in Drug of Abuse Testing 6. Competition Dynamics 6.1. Company Share Analysis (2018) 6.2. Top 10 Product Pricing by Region 7. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Test Type 7.1. Key Market Findings 7.2. Long Term ROI Segments 7.3. Revenue Opportunity Influencing Factors 7.4. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 7.4.1 Immunoassay Test 7.4.2 POCT Tests 7.4.3 Chromatography Tests 7.4.4 Academic Institutes 8. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Sample Type 8.1. Key Market Findings 8.2. Long Term ROI Segments 8.3. Revenue Opportunity Influencing Factors 8.4. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 8.4.1 Urine 8.4.2 Saliva 8.4.3 Blood 8.4.4 Others 9. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by End User 9.1. Key Market Findings 9.2. Long Term ROI Segments 9.3. Revenue Opportunity Influencing Factors 9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 20182026 9.4.1 Pathology Laboratories 9.4.2 Hospitals 9.4.3 Rehabilitation Centres 9.4.4 Federal Agencies 9.4.5 Forensic Laboratories 9.4.6 Clinics 9.4.7 Others 10. Global Drug of Abuse Testing Market Revenue (USD Mn), 2018-2026 by Region 10.1.Key Market Findings 10.2.Long Term ROI Segments 10.3.Revenue Opportunity Influencing Factors 10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026 10.4.1 North America 10.4.2 Latin America 10.4.3 Europe 10.4.4 Asia Pacific 10.4.5 Rest of world 11. North America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026 11.1. Key Market Findings 11.2. Long Term ROI Segments 11.3. Revenue Opportunity Influencing Factors 11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 11.4.1 US 11.4.2 Canada 11.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 11.5.3 Immunoassay Test 11.5.4 POCT Tests 11.5.5 Chromatography Tests 11.5.6 Academic Institutes 11.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 11.6.7 Urine 11.6.8 Saliva 11.6.9 Blood 11.6.10 Others 11.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 11.7.11 Pathology Laboratories 11.7.12 Hospitals 11.7.13 Rehabilitation Centres 11.7.14 Federal Agencies 11.7.15 Forensic Laboratories 11.7.16 Clinics 11.7.17 Others 12. Latin America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026 12.1. Key Market Findings 12.2. Long Term ROI Segments 12.3. Revenue Opportunity Influencing Factors 12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 12.4.1 Brazil 12.4.2 Mexico 12.4.3 Argentina 12.4.4 Rest of Latin America 12.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 12.5.5 Immunoassay Test 12.5.6 POCT Tests 12.5.7 Chromatography Tests 12.5.8 Academic Institutes 12.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 12.6.9 Urine 12.6.10 Saliva 12.6.11Blood 12.6.12 Others 12.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 12.7.13 Pathology Laboratories 12.7.14 Hospitals 12.7.15 Rehabilitation Centres 12.7.16 Federal Agencies 12.7.17 Forensic Laboratories 12.7.18 Clinics 12.7.19 Others 13. Europe America Drug of Abuse Testing Market Revenue (US$ Mn), 2018-2026 13.1. Key Market Findings 13.2. Long Term ROI Segments 13.3. Revenue Opportunity Influencing Factors 13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 13.4.1 Germany 13.4.2 France 13.4.3 Spain 13.4.4 UK 13.4.5 Russia 13.4.6 Poland 13.4.7 Rest of Europe 13.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 13.5.8 Immunoassay Test 13.5.9 POCT Tests 13.5.10Chromatography Tests 13.5.11Academic Institutes 13.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 13.6.12Urine 13.6.13Saliva 13.6.14Blood 13.6.15 Others 13.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 13.7.16 Pathology Laboratories 13.7.17 Hospitals 13.7.18 Rehabilitation Centres 13.7.19 Federal Agencies 13.7.20 Forensic Laboratories 13.7.21 Clinics 13.7.22 Others 14. Asia Pacific America Drug of Abuse Testing Market Revenue (US$ Mn), 20182026 14.1. Key Market Findings 14.2. Long Term ROI Segments 14.3. Revenue Opportunity Influencing Factors 14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 14.4.1 Emerging Asia 14.4.1.1 China 14.4.1.2 India 14.4.1.3 ASEAN-5 14.4.1.4 Rest of Emerging Asia 14.4.2 Japan 14.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 14.5.3 Immunoassay Test 14.5.4 POCT Tests 14.5.5 Chromatography Tests 14.5.6 Academic Institutes 14.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 14.6.7 Urine 14.6.8 Saliva 14.6.9 Blood 14.6.10 Others 14.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 14.7.11 Pathology Laboratories 14.7.12 Hospitals 14.7.13 Rehabilitation Centres 14.7.14 Federal Agencies 14.7.15 Forensic Laboratories 14.7.16 Clinics 14.7.17 Others 15. Rest of World America Drug of Abuse Testing Market Revenue (US$ Mn), 20182026 15.1. Key Market Findings 15.2. Long Term ROI Segments 15.3. Revenue Opportunity Influencing Factors 15.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 15.4.1 Middle East 15.4.2 South Africa 15.4.3 North Africa 15.4.4 Rest of World 15.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2018-2026 15.5.5 Immunoassay Test 15.5.6 POCT Tests 15.5.7 Chromatography Tests 15.5.8 Academic Institutes 15.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2018-2026 15.6.9 Urine 15.6.10Saliva 15.6.11Blood 15.6.12 Others 15.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026 15.7.13 Pathology Laboratories 15.7.14 Hospitals 15.7.15 Rehabilitation Centres 15.7.16 Federal Agencies 15.7.17 Forensic Laboratories 15.7.18 Clinics 15.7.19 Others 16. Company Profiles 16.1. Competition Landscape 16.2. Global Company Share (USD Mn) Overview, 2018 16.3. Company Profiles 16.3.1 Thermo Fisher Scientific 16.3.1.1 Corporate Overview 16.3.1.2 Financial Performance 16.3.1.3 Peer Comparison & 3C marketing equation 16.3.1.4 Company Strategy & Channel Management 16.3.2 SYNLAB 16.3.2.1 Corporate Overview 16.3.2.2 Financial Performance 16.3.2.3 Peer Comparison & 3C marketing equation 16.3.2.4 Company Strategy & Channel Management 16.3.3 Siemens Healthcare Private Limited 16.3.3.1 Corporate Overview 16.3.3.2 Financial Performance 16.3.3.3 Peer Comparison & 3C marketing equation 16.3.3.4 Company Strategy & Channel Management 16.3.4 Roche Diagnostics 16.3.4.1 Corporate Overview 16.3.4.2 Financial Performance 16.3.4.3 Peer Comparison & 3C marketing equation 16.3.4.4 Company Strategy & Channel Management 16.3.5 Drägerwerk AG & Co. KGaA 16.3.5.1 Corporate Overview 16.3.5.2 Financial Performance 16.3.5.3 Peer Comparison & 3C marketing equation 16.3.5.4 Company Strategy & Channel Management 16.3.6 Beckman Coulter, Inc. 16.3.6.1 Corporate Overview 16.3.6.2 Financial Performance 16.3.6.3 Peer Comparison & 3C marketing equation 16.3.6.4 Company Strategy & Channel Management 16.3.7 Abbott Laboratories 16.3.7.1 Corporate Overview 16.3.7.2 Financial Performance 16.3.7.3 Peer Comparison & 3C marketing equation 16.3.7.4 Company Strategy & Channel Management 17. Research Sources & Primary Verbatim Inquire further details about this report at: [email protected] About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
A considerable rise in cases of drug abuse due to opium dependency and confusion between CBD based medical marijuana and marijuana that creates a high is emphasizing the need for drug abuse testing. Increase in mortality rate due to drug abuse is causing the governments to impose strict regulations to make drug of abuse tests mandatory for employment, criminal justice cases and protection for social causes. Besides the advancements in test equipment technology that facilitate quick and ultrasensitive detections of newly formulated abusive drugs. Above mentioned the market stimulants causing a significant upsurge in the global drug of abuse testing market.
© Copyright 2024 Paperzz
